Federal contracts
$20Kcommitted so far
Balversa 4 mg
The Department of Veterans Affairs has committed $20K to Johnson & Johnson so far. It runs until Mar 24, 2026.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 13, 2026 · Filed Feb 19, 2026
Johnson & Johnson's CIO sold $4.72M of Johnson & Johnson shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$4,721,144
Shares × reported transaction price
23 days after results of Jan 21, 2026, 60 days before results of Apr 14, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $243.45 on Feb 13, 2026, within 1% of its 52-week high, after an 18% rise over the previous 30 trading days
52-week range $146.36 (May 14, 2025) to $244.55 (Feb 12, 2026), 99% of the way up, from 251 adjusted closes. 30 trading days earlier: $206.95 on Dec 31, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
FDA approved Rybrevant Faspro on Feb 13, 2026, the same day as this trade.
Biologic approved. Active ingredient: Amivantamab and Hyaluronidase-Lpuj. From openFDA. Dates only; no link between the two is implied
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.4% | +0.7% | −2.1% |
| 30 days | −4.7% | −4.3% | −0.4% |
| 90 days | −7.1% | +8.3% | −15.4% |
| 180 days | +9.8% | +12.1% | −2.3% |
Past results only. Not a forecast.
Federal contracts
Balversa 4 mg
The Department of Veterans Affairs has committed $20K to Johnson & Johnson so far. It runs until Mar 24, 2026.
Insider filing
Traded Mar 4, 2025 · filed 374 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 10 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.